World News

FDA Grants Regular Approval to Rucaparib for Metastatic Castration-Resistant Prostate Cancer

Ogkologos - 29 Ιανουαρίου, 2026

ESMO Clinical Practice Guideline Express Update on the management of epithelial...

Ogkologos - 28 Ιανουαρίου, 2026

FDA Approves Lisocabtagene Maraleucel for Relapsed or Refractory Marginal Zone Lymphoma

Ogkologos - 28 Ιανουαρίου, 2026

ESMO Clinical Practice Guideline Express Update on the adoption of physical...

Ogkologos - 27 Ιανουαρίου, 2026

Mortality Trends for Most Cancers Remain Favourable In the EU, Although...

Ogkologos - 27 Ιανουαρίου, 2026

Abemaciclib Improves PFS at Six Months Among Patients with High-Grade Meningiomas...

Ogkologos - 26 Ιανουαρίου, 2026

N-of-1 Tailored Combination Therapy Matched to the Molecular Alterations, Facilitated by...

Ogkologos - 23 Ιανουαρίου, 2026

European Parliament Adopts Its Position on the Critical Medicines Act, Strengthening...

Ogkologos - 22 Ιανουαρίου, 2026

FDA Grants Traditional Approval to Tarlatamab-dlle for Extensive Stage Small Cell...

Ogkologos - 22 Ιανουαρίου, 2026

ESMO Raises Key Issues on Cancer Prevention and Care at the...

Ogkologos - 21 Ιανουαρίου, 2026

1...272829...432 Σελίδα 28 από 432

MOST POPULAR

Tucatinib Added to Trastuzumab and Capecitabine Continues to Demonstrate a Significant...

19 Ιανουαρίου, 2022

Savolitinib Plus Osimertinib Show a High Response in EGFR-mutated NSCLC Progressed...

6 Αυγούστου, 2025

Apalutamide Plus ADT Provides Significant Improvement in Overal Survival and Delays...

6 Μαΐου, 2021

Efficacy of a Bispecific Monoclonal Antibody Glofitamab for Relapsed or Refractory...

19 Δεκεμβρίου, 2022

Φόρτωση περισσοτέρων

FDA Grants Regular Approval to Rucaparib for Metastatic Castration-Resistant Prostate Cancer

ESMO Clinical Practice Guideline Express Update on the management of epithelial...

FDA Approves Lisocabtagene Maraleucel for Relapsed or Refractory Marginal Zone Lymphoma

ESMO Clinical Practice Guideline Express Update on the adoption of physical...

Mortality Trends for Most Cancers Remain Favourable In the EU, Although...

Abemaciclib Improves PFS at Six Months Among Patients with High-Grade Meningiomas...

N-of-1 Tailored Combination Therapy Matched to the Molecular Alterations, Facilitated by...

European Parliament Adopts Its Position on the Critical Medicines Act, Strengthening...

FDA Grants Traditional Approval to Tarlatamab-dlle for Extensive Stage Small Cell...

ESMO Raises Key Issues on Cancer Prevention and Care at the...

MOST POPULAR

Tucatinib Added to Trastuzumab and Capecitabine Continues to Demonstrate a Significant...

Savolitinib Plus Osimertinib Show a High Response in EGFR-mutated NSCLC Progressed...

Apalutamide Plus ADT Provides Significant Improvement in Overal Survival and Delays...

Efficacy of a Bispecific Monoclonal Antibody Glofitamab for Relapsed or Refractory...

HOT NEWS

Men’s skin cancer rates increase by 50% over decade

How to Get Started With Exercising at Home During Cancer

The Doctor Will See You Now…On the Screen

Coverage for Breast Cancer Genetic Marker Testing is Still Being Denied...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ